Published in Women's Health Weekly, October 1st, 2009
"This nanoparticle targets uPA receptor, which is overexpressed in breast cancer tissues. ATF-IO nanoparticles are able to specifically bind to and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly